<DOC>
	<DOCNO>NCT01814670</DOCNO>
	<brief_summary>A study evaluate safety efficacy treatment botulinum toxin Type A ( BOTOX® ) Chinese patient moderate severe frown line ( Glabellar Rhytides ) previously treat facial laser resurfacing .</brief_summary>
	<brief_title>Treatment With Botulinum Toxin Type A ( BOTOX® ) Chinese Patients With Moderate Severe Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>moderate severe frown line facial laser treatment 4 8 week prior Day 1 previous use botulinum toxin indication diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis microdermabrasion superficial peel , permanent makeup brow forehead area within last 3 month facial cosmetic procedure within last 6 Months treatment forehead , brow , nose midface area filler within last 12 month use new topical skin care product within 1 month screen prior forehead periorbital surgery brow lift deep dermal scarring , excessively thick sebaceous skin , and/ loss skin elasticity facial skin infection unhealed skin lesion pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>